How big is the tenosynovitis drugs market today, and what are its future growth expectations?
The tenosynovitis drugs market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.29 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increase in incidence of sport injuries, growth in aging population, rise in healthcare expenditure, increase in awareness about tenosynovitis, and increase in adoption of biologic treatments.
The tenosynovitis drugs market size is expected to see strong growth in the next few years. It will grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to rising telehealth services, expansion of global health initiatives, rising prevalence of musculoskeletal disorders, growing demand for tenosynovitis drugs, and rising prevalence of chronic diseases. Major trends in the forecast period include advancements in surgical techniques, integration of robotics in surgery, advancements in minimally invasive procedures, advancements in nanotechnology, and innovation in drug formulation.
Get Your Free Sample of The Global Tenosynovitis Drugs Market Report:
Tenosynovitis Drugs Market Research And Trends Report 2025-2034 Sample
What have been the primary factors driving the tenosynovitis drugs market’s growth?
The growing prevalence of musculoskeletal disorders is expected to drive the growth of the tenosynovitis drugs market going forward. Musculoskeletal disorders are injuries affecting muscles, tendons, ligaments, nerves, and joints, impacting movement and causing pain. The growing prevalence of musculoskeletal disorders is attributed to aging populations, sedentary lifestyles, and increased occupational hazards. Tenosynovitis drugs, including anti-inflammatory medications and corticosteroids, are used to reduce inflammation and alleviate pain in musculoskeletal disorders affecting tendons and their sheaths. For instance, in March 2023, according to the Office for Health Improvement and Disparities, a UK-based government department for public health, in 2022, 17.6% of people aged 16 and over reported having a long-term musculoskeletal (MSK) condition, such as arthritis or ongoing back or joint problems, up from 17.0% in 2021. Therefore, the growing prevalence of musculoskeletal disorders is driving the growth of the tenosynovitis drugs market.
Rising Sports Injuries Fuel Demand For Advanced Therapeutics
The increasing incidence of sports injuries is expected to drive the growth of the tenosynovitis drugs market going forward. Sports injuries refer to physical injuries sustained during athletic activities or exercise, ranging from minor sprains and strains to more severe fractures or dislocations. Sports injuries are attributed to various factors such as overuse, improper technique, insufficient warm-up or stretching, and collisions with other players or objects. Tenosynovitis drugs are used in treating sports injuries by reducing tendon inflammation and alleviating pain, enabling faster recovery and improved mobility. For instance, in November 2023, according to the Howden Group Holdings Ltd, a UK-based insurance intermediary company, the severity of ankle injuries in the English Premier League surged by 170% between October 2022 and January 2023, with calf/shin injuries increasing by 200% and hamstring injuries by 130%, following the FIFA World Cup Qatar 2022. Therefore, the increasing incidence of sports injuries is driving the growth of the tenosynovitis drugs market.
What are the key segments within the tenosynovitis drugs market?
The tenosynovitis drugs market covered in this report is segmented –
1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Corticosteroids, Antibiotics, Other Drug Types
2) By Indication: De Quervain Tenosynovitis, Stenosing Tenosynovitis, Trigger Finger, Other Indications
3) By Route Of Administration: Oral, Injectable, Topical
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib
2) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Triamcinolone
3) By Antibiotics: Penicillins, Cephalosporins, Fluoroquinolones, Macrolides
4) By Other Drug Types: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Biologics, Analgesics
Order your report now for swift delivery
Tenosynovitis Drugs Market Research And Trends Report 2025-2034
Which key players are shaping the tenosynovitis drugs market?
Major companies operating in the tenosynovitis drugs market are Pfizer Inc., Roche Holding AG, Bayer AG, Sanofi S.A., AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals, Zydus Cadila Healthcare, AdvaCare Pharma.
How will emerging trends drive the tenosynovitis drugs market throughout the forecast period?
Major companies operating in the tenosynovitis drugs market are focusing on formulation advancements to improve efficacy, minimize side effects, and enhance patient adherence. Advanced drug formulations, such as delayed-release and controlled-release technologies, help provide prolonged therapeutic effects, reduce dosing frequency, and minimize gastrointestinal irritation, improving overall patient comfort and compliance. For instance, in July 2024, ANI Pharmaceuticals Inc., a US-based pharmaceutical company, announced that it had received U.S. Food and Drug Administration (FDA) approval for its abbreviated new drug application (ANDA) and had launched Naproxen delayed-release tablets, USP. This medication was introduced as the generic equivalent of the reference listed drug (RLD), EC-Naprosyn, providing the same therapeutic benefits at a more affordable price. The delayed-release formulation was designed to offer extended pain relief while reducing gastric irritation, making it a beneficial treatment for inflammatory conditions such as arthritis, tendonitis, and tenosynovitis.
How do regional factors impact the tenosynovitis drugs market, and which region is the largest contributor?
North America was the largest region in the tenosynovitis drugs market in 2024. The regions covered in the tenosynovitis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Tenosynovitis Drugs Market Report 2025 Offer?
The tenosynovitis drugs market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Tenosynovitis drugs are medications used to reduce inflammation, pain, and swelling in the tendon sheath caused by conditions like infection, overuse, or autoimmune diseases. Treatment options include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and antibiotics for infectious cases. In severe cases, disease-modifying antirheumatic drugs (DMARDs) or biologics may be used for chronic inflammatory forms.
Purchase the exclusive report now to unlock valuable market insights:
Tenosynovitis Drugs Market Research And Trends Report 2025-2034
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: In-Depth Insights into the Implantable Loop Recorders Market: Growth, Trends, and Opportunities for 2025-2034 – Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports – By The Business Research Company
Global Market Model: Global Market Intelligence Database
